Vistagen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

Compare

0.5300

+0.0244 (4.83%)

At close: Feb 17, 2026, 4:00 PM EST

0.5474

+0.0174 (3.28%)

Pre-market: Feb 18, 2026, 4:29 AM EST

Vistagen Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-67.05	-51.42	-29.36	-59.25	-47.76	-17.93
Depreciation & Amortization	0.71	0.64	0.57	0.53	0.71	0.48
Other Amortization	-	-	-	-	0.23	-
Loss (Gain) From Sale of Assets	-	-	0.01	-	-	-
Loss (Gain) From Sale of Investments	-0.54	-0.39	-	-	-	-
Stock-Based Compensation	4.07	4.32	2.18	3.34	3.48	2.31
Other Operating Activities	0	-	-	3.64	-	-
Change in Accounts Payable	4.03	5.68	0.52	-0.93	1.69	0.05
Change in Unearned Revenue	-0.71	-0.41	0.52	0.21	-1	3.67
Change in Other Net Operating Assets	-0.81	-0.51	-0.25	2.76	-2.6	-0.64
Operating Cash Flow	-60.3	-42.1	-25.81	-49.72	-45.26	-12.07
Capital Expenditures	-0.24	-0.19	-0.06	-0.21	-0.2	-0.28
Cash Acquisitions	-	-	-	-0.53	-	-
Investment in Securities	-0.01	-12.96	-	-	-	-
Investing Cash Flow	-0.25	-13.15	-0.06	-0.74	-0.2	-0.28
Short-Term Debt Issued	-	-	-	-	-	0.22
Total Debt Issued	1.02	-	-	-	-	0.22
Short-Term Debt Repaid	-	-	-0.99	-1.03	-	-0.6
Long-Term Debt Repaid	-	-	-	-	-0	-0
Total Debt Repaid	-0.64	-	-0.99	-1.03	-0	-0.61
Net Debt Issued (Repaid)	0.38	-	-0.99	-1.03	-0	-0.38
Issuance of Common Stock	32.83	3.21	129.39	0.17	10.49	114.48
Other Financing Activities	-	-	-	-0.17	-	-
Financing Cash Flow	33.21	3.21	128.4	-1.04	10.48	114.1
Net Cash Flow	-27.34	-52.04	102.53	-51.5	-34.97	101.75
Free Cash Flow	-60.54	-42.29	-25.87	-49.93	-45.46	-12.35
Free Cash Flow Margin	-7672.62%	-8701.24%	-2431.77%	-	-4099.28%	-1133.45%
Free Cash Flow Per Share	-1.71	-1.37	-1.34	-7.17	-6.89	-4.30
Cash Interest Paid	0.03	-	-	-	-	0.01
Cash Income Tax Paid	-	-	-	-	-	0
Levered Free Cash Flow	-36.17	-23.27	-18	-32.74	-25.98	-8.07
Unlevered Free Cash Flow	-36.17	-23.27	-18	-32.74	-26.21	-8.06
Change in Working Capital	2.51	4.76	0.79	2.03	-1.92	3.08

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q